LivaNova Sells Surgical Heart Valve Business To Gyrus Capital For $73M

 
• By Reed Miller

Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.

Investing in new business while divesting in old industry with an old tree shaped as a finance pie chart graph funding a green tree
• Source: shutterstock.com

More from Strategy

More from Business